216 related articles for article (PubMed ID: 17607649)
1. [Fabry disease: demographic data since introduction of enzyme replacement therapy].
Cybulla M; Walter K; Neumann HP; Widmer U; Schärer M; Sunder-Plassmann G; Jansen T; Rolfs A; Beck M
Dtsch Med Wochenschr; 2007 Jul; 132(28-29):1505-9. PubMed ID: 17607649
[TBL] [Abstract][Full Text] [Related]
2. Fabry disease and the skin: data from FOS, the Fabry outcome survey.
Orteu CH; Jansen T; Lidove O; Jaussaud R; Hughes DA; Pintos-Morell G; Ramaswami U; Parini R; Sunder-Plassman G; Beck M; Mehta AB;
Br J Dermatol; 2007 Aug; 157(2):331-7. PubMed ID: 17573884
[TBL] [Abstract][Full Text] [Related]
3. [Fabry's disease: diagnosis in the pediatric age group].
Pintos Morell G
An Esp Pediatr; 2002 Jul; 57(1):45-50. PubMed ID: 12139892
[TBL] [Abstract][Full Text] [Related]
4. Ocular manifestations of Fabry's disease: data from the Fabry Outcome Survey.
Sodi A; Ioannidis AS; Mehta A; Davey C; Beck M; Pitz S
Br J Ophthalmol; 2007 Feb; 91(2):210-4. PubMed ID: 16973664
[TBL] [Abstract][Full Text] [Related]
5. [Ocular findings in Fabry's disease].
Kuzman T; Juri J; Mrsić M; Jeren-Strujić B; Mandić Z; Sikić J
Acta Med Croatica; 2006; 60(2):163-6. PubMed ID: 16848212
[TBL] [Abstract][Full Text] [Related]
6. Neurological manifestations in Fabry's disease.
Møller AT; Jensen TS
Nat Clin Pract Neurol; 2007 Feb; 3(2):95-106. PubMed ID: 17279083
[TBL] [Abstract][Full Text] [Related]
7. [Renal involvement in Fabry's disease: diagnosis, follow-up and enzyme replacement therapy].
Mignani R; Feriozzi S; Carraro G; Martinelli F; Cianciaruso B
G Ital Nefrol; 2009; 26(5):577-84. PubMed ID: 19802803
[TBL] [Abstract][Full Text] [Related]
8. Fabry disease in Spain: description of Spanish patients and a comparison with other European countries using data from the Fabry Outcome Survey (FOS).
Barba-Romero MÁ; Rivera-Gallego A; Pintos-Morell G;
Int J Clin Pract; 2011 Aug; 65(8):903-10. PubMed ID: 21679285
[TBL] [Abstract][Full Text] [Related]
9. Hyperhidrosis: a new and often early symptom in Fabry disease. International experience and data from the Fabry Outcome Survey.
Lidove O; Ramaswami U; Jaussaud R; Barbey F; Maisonobe T; Caillaud C; Beck M; Sunder-Plassmann G; Linhart A; Mehta A;
Int J Clin Pract; 2006 Sep; 60(9):1053-9. PubMed ID: 16939546
[TBL] [Abstract][Full Text] [Related]
10. [Fabry disease in Italy: first epidemiologic and collaborative study].
Ricci R; Castorina M; Di Lillo M; Antuzzi D; Frustaci A; Parini R; Menni F; Furlan F; Burlina A; Burlina A; Catuogno S; Gabrielli O; Burattini I; Borsini W; Buchner S; Ferriozzi S; Spisni C; De Vito R; Di Rocco M; Aricò M; Pistone G; Bongiorno AM; Morrone A; Cavicchi C; Zammarchi E
Ann Ital Med Int; 2004; 19(4):269-75. PubMed ID: 15678707
[TBL] [Abstract][Full Text] [Related]
11. Distal extremity pain as a presenting feature of Fabry's disease.
Pagnini I; Borsini W; Cecchi F; Sgalambro A; Olivotto I; Frullini A; Cimaz R
Arthritis Care Res (Hoboken); 2011 Mar; 63(3):390-5. PubMed ID: 20981813
[TBL] [Abstract][Full Text] [Related]
12. [Fabry's disease; towards a treatment].
Linthorst GE; Hollak CE; Bosman DK; Heymans HS; Aerts JM
Ned Tijdschr Geneeskd; 2000 Dec; 144(50):2391-5. PubMed ID: 11145093
[TBL] [Abstract][Full Text] [Related]
13. [Evaluation of patients with Fabry disease in Argentina].
AADELFA (Asociación Argentina de estudio de enfermedad de Fabry y otras enfermedades lisosomales)
Medicina (B Aires); 2010; 70(1):37-43. PubMed ID: 20228022
[TBL] [Abstract][Full Text] [Related]
14. A study on serum IgE and clinical symptomatology of atopy in patients suffering from the lysosomal storage disorder Fabry disease.
Möhrenschlager M; Ollert M; Ring J
J Eur Acad Dermatol Venereol; 2008 Jun; 22(6):692-5. PubMed ID: 18384565
[TBL] [Abstract][Full Text] [Related]
15. Fabry disease: an ultrastructural comparative study of skin in hemizygous and heterozygous patients.
Navarro C; Teijeira S; Dominguez C; Fernandez JM; Rivas E; Fachal C; Barrera S; Rodriguez C; Iranzo P
Acta Neuropathol; 2006 Feb; 111(2):178-85. PubMed ID: 16463201
[TBL] [Abstract][Full Text] [Related]
16. Nephropathy in males and females with Fabry disease: cross-sectional description of patients before treatment with enzyme replacement therapy.
Ortiz A; Oliveira JP; Waldek S; Warnock DG; Cianciaruso B; Wanner C;
Nephrol Dial Transplant; 2008 May; 23(5):1600-7. PubMed ID: 18175781
[TBL] [Abstract][Full Text] [Related]
17. [Fabry's disease and hypoparathyroidism].
Misery L; Gregoire M; Prieur F; Froissart R; Guffon N; Maitre S; Fond L; Denis L; Perrot JL; Cambazard F
Ann Med Interne (Paris); 2002 Jun; 153(4):283-5. PubMed ID: 12218896
[TBL] [Abstract][Full Text] [Related]
18. Fabry's disease: a prospective multicenter cohort study in young adults with cryptogenic stroke.
Saposnik G; Lanthier S; Mamdani M; Thorpe KE; Melo M; Pope K; Selchen D; Moore DF; ;
Int J Stroke; 2012 Apr; 7(3):265-73. PubMed ID: 22264232
[TBL] [Abstract][Full Text] [Related]
19. Effects of enzyme replacement therapy on the cardiomyopathy of Anderson-Fabry disease: a randomised, double-blind, placebo-controlled clinical trial of agalsidase alfa.
Hughes DA; Elliott PM; Shah J; Zuckerman J; Coghlan G; Brookes J; Mehta AB
Heart; 2008 Feb; 94(2):153-8. PubMed ID: 17483124
[TBL] [Abstract][Full Text] [Related]
20. Hearing loss in Fabry disease: data from the Fabry Outcome Survey.
Hegemann S; Hajioff D; Conti G; Beck M; Sunder-Plassmann G; Widmer U; Mehta A; Keilmann A
Eur J Clin Invest; 2006 Sep; 36(9):654-62. PubMed ID: 16919049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
